Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by PFIZER

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
009127 New Drug Application Approval New manufacturer (S) Standard review drug
009164 New Drug Application Approval New manufacturer (S) Standard review drug
009996 New Drug Application Approval New manufacturer (S) Standard review drug
010392 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
010554 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
010686 New Drug Application Approval New manufacturer (S) Standard review drug
011111 New Drug Application Approval New formulation (S) Standard review drug
011210 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
011446 New Drug Application Approval New manufacturer (S) Standard review drug
011459 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
011612 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
011641 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
011795 New Drug Application Approval New formulation (S) Standard review drug
012128 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
012845 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
013636 New Drug Application Approval New combination (S) Standard review drug
016584 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
016758 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
016798 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
016820 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
016834 New Drug Application Approval New formulation (S) Standard review drug
016904 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
017442 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
017516 New Drug Application Approval New formulation (S) Standard review drug
017783 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
017986 New Drug Application Approval New combination (S) Standard review drug
018069 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
018147 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
018353 New Drug Application Approval New formulation (P) Priority review drug
018482 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
018682 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
018989 New Drug Application Approval New formulation (P) Priority review drug
019152 New Drug Application Approval New formulation (S) Standard review drug
019440 New Drug Application Approval New formulation (S) Standard review drug
019668 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
019684 New Drug Application Approval New formulation (S) Standard review drug
019771 New Drug Application Approval New combination (S) Standard review drug
019775 New Drug Application Approval New formulation (S) Standard review drug
019787 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
019839 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
019949 New Drug Application Approval New molecular entity (NME) (P*) Priority review drug*
019950 New Drug Application Approval New formulation (S*) Standard review drug*
020090 New Drug Application Approval New formulation (S*) Standard review drug*
020267 New Drug Application Approval New formulation (S) Standard review drug
020329 New Drug Application Approval New formulation (S) Standard review drug
020402 New Drug Application Approval New formulation (S) Standard review drug
020555 New Drug Application Approval New formulation (S) Standard review drug
020589 New Drug Application Approval OTC (over-the-counter) switch (S) Standard review drug
020702 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020755 New Drug Application Approval New manufacturer (S) Standard review drug
020759 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020760 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020812 New Drug Application Approval New formulation (S) Standard review drug
020825 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020859 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020883 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020919 New Drug Application Approval New formulation (S) Standard review drug
020931 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020944 New Drug Application Approval New formulation
020990 New Drug Application Approval New formulation (S) Standard review drug
021269 New Drug Application Approval New formulation (S) Standard review drug
021373 New Drug Application Approval New formulation (S) Standard review drug
021374 New Drug Application Approval New formulation (S) Standard review drug
021375 New Drug Application Approval New formulation (S) Standard review drug
021393 New Drug Application Approval New combination (S) Standard review drug
021394 New Drug Application Approval New combination (S) Standard review drug
021441 New Drug Application Approval New combination (S) Standard review drug
021464 New Drug Application Approval New indication (S) Standard review drug
021466 New Drug Application Approval New indication (S) Standard review drug
021540 New Drug Application Approval New combination (S) Standard review drug
021584 New Drug Application Approval New indication (S) Standard review drug
021587 New Drug Application Approval New formulation (S) Standard review drug
021845 New Drug Application Approval New manufacturer (P) Priority review drug
021868 New Drug Application Approval New formulation (S) Standard review drug
021948 New Drug Application Approval New indication (P) Priority review drug
022030 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
022113 New Drug Application Approval New combination (S) Standard review drug
022458 New Drug Application Approval New molecular entity (NME) (S) Standard review drug (V) Orphan drug
022473 New Drug Application Approval New formulation (S) Standard review drug
022565 New Drug Application Approval New combination (S) Standard review drug
050006 New Drug Application Approval
050007 New Drug Application Approval
050109 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
050286 New Drug Application Approval
050287 New Drug Application Approval
050332
TAO
New Drug Application Approval
050336
TAO
New Drug Application Approval
050347 New Drug Application Approval
050435 New Drug Application Approval
050442 New Drug Application Approval
050480 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
050520 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
050533 New Drug Application Approval New formulation (S) Standard review drug
050551 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
050556 New Drug Application Approval New formulation (S) Standard review drug
050608 New Drug Application Approval New molecular entity (NME); New combination (S) Standard review drug
050613 New Drug Application Approval New formulation (S) Standard review drug
050670 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
050693 New Drug Application Approval New formulation (S) Standard review drug
050710 New Drug Application Approval New formulation (S) Standard review drug
050711 New Drug Application Approval New formulation (S) Standard review drug
050730 New Drug Application Approval New formulation (P) Priority review drug
050733 New Drug Application Approval New formulation (S) Standard review drug
050762 New Drug Application Approval New combination (S) Standard review drug
050784 New Drug Application Approval New formulation (S) Standard review drug
060014 Abbreviated New Drug Application Approval
060074 Abbreviated New Drug Application Approval
060075 Abbreviated New Drug Application Approval
060076 Abbreviated New Drug Application Approval
060096 Abbreviated New Drug Application Approval
060099 Abbreviated New Drug Application Approval
060111 Abbreviated New Drug Application Approval
060282 Abbreviated New Drug Application Approval
060285 Abbreviated New Drug Application Approval
060286 Abbreviated New Drug Application Approval
060475 Abbreviated New Drug Application Approval
060567 Abbreviated New Drug Application Approval
060586 Abbreviated New Drug Application Approval
060587 Abbreviated New Drug Application Approval
060595 Abbreviated New Drug Application Approval
060657 Abbreviated New Drug Application Approval
061009 Abbreviated New Drug Application Approval
061015 Abbreviated New Drug Application Approval
061016 Abbreviated New Drug Application Approval
061086 Abbreviated New Drug Application Approval
061791 Abbreviated New Drug Application Approval
061815 Abbreviated New Drug Application Approval
061836 Abbreviated New Drug Application Approval
061841 Abbreviated New Drug Application Approval
062049 Abbreviated New Drug Application Approval
062050 Abbreviated New Drug Application Approval
062901 Abbreviated New Drug Application Approval
063333 Abbreviated New Drug Application Approval
075822 Abbreviated New Drug Application Approval
201370 New Drug Application Approval New manufacturer (S) Standard review drug
203109 New Drug Application Approval New formulation (P) Priority review drug

Back to Companies who have applied for FDA Drug Approval